Drs Camidge and Blue discussed Dr Blue’s journey into practicing medicine, and speciaffly how he settled on treating malignant hematologic conditions.
Brandon Blue, MD
Advertisement
Articles by Brandon Blue, MD
Brandon Blue, MD, discusses the importance of early intervention in relapsed/refractory multiple myeloma.
Brandon Blue, MD, discusses treatment considerations for patients with relapsed/refractory multiple myeloma.
Brandon Blue, MD, discusses the utility of carfilzomib in relapsed/refractory multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Blue on the Utility of Carfilzomib in Relapsed/Refractory Multiple MyelomaPublished: October 1st 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5